FLUOR CORP
For the period ended Sep 30, 2024. Filed Nov 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 8, 2024
FLR$50.33+8.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheet
CONDENSED CONSOLIDATED BALANCE SHEET
| (in millions, except share and per share amounts) | September 30,2024 | December 31,2023 |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents ($518 and $491 related to VIEs) | $2,912 | $2,519 |
| Marketable securities ($25 and $0 related to VIEs) | 94 | 69 |
| Accounts receivable, net ($152 and $135 related to VIEs) | 1,049 | 1,137 |
| Contract assets ($160 and $171 related to VIEs) | 1,063 | 991 |
| Other current assets ($48 and $50 related to VIEs) | 147 | 347 |
| Total current assets | 5,265 | 5,063 |
| Noncurrent assets | ||
| PP&E, net ($52 and $41 related to VIEs) | 504 | 458 |
| Investments | 612 | 614 |
| Deferred taxes | 38 | 51 |
| Deferred compensation trusts | 223 | 241 |
| Goodwill | 206 | 206 |
| Other assets ($80 and $127 related to VIEs) | 252 | 340 |
| Total noncurrent assets | 1,835 | 1,910 |
| Total assets | $7,100 | $6,973 |
| LIABILITIES AND EQUITY | ||
| Current liabilities | ||
| Accounts payable ($319 and $285 related to VIEs) | $1,195 | $1,214 |
| Contract liabilities ($271 and $276 related to VIEs) | 684 | 639 |
| Accrued salaries, wages and benefits ($25 related to VIEs in both periods) | 608 | 653 |
| Other accrued liabilities ($73 related to VIEs in both periods) | 495 | 657 |
| Total current liabilities | 2,982 | 3,163 |
| Long-term debt | 1,116 | 1,158 |
| Deferred taxes | 80 | 70 |
| Other noncurrent liabilities ($82 and $20 related to VIEs) | 581 | 530 |
| Commitments and contingencies | ||
| Equity | ||
| Shareholders’ equity | ||
| Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 171,326,177 and 170,405,512 shares in 2024 and 2023, respectively | 2 | 2 |
| APIC | 1,286 | 1,228 |
| AOCI | (298) | (269) |
| Retained earnings | 1,261 | 979 |
| Total shareholders’ equity | 2,251 | 1,940 |
| NCI | 90 | 112 |
| Total equity | 2,341 | 2,052 |
| Total liabilities and equity | $7,100 | $6,973 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.